Fetal HDL/apoE: A novel regulator of gene expression in human placental endothelial Cells

Physiological Genomics

Volumn 43, Issue 22, 2011, Pages 1255-1262

  Augsten, Manuela ^a   Hackl, Hubert ^b   Ebner, Birgit ^a   Chemelli, Angela ^c   Glatter, Otto ^c   Marsche, Gunther ^a   Lang, Uwe ^a   Desoye, Gernot ^a   Wadsack, Christian ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cholesterol biosynthesis; Metallothioneins; Microarray analysis; Reconstituted high density lipoprotein particle

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; METALLOTHIONEIN;

ARTICLE; CHOLESTEROL SYNTHESIS; DOWN REGULATION; ENDOTHELIUM CELL; FETUS; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYDRODYNAMICS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PLACENTA; PRIORITY JOURNAL; UPREGULATION;

ADULT; APOLIPOPROTEINS E; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; LIPOPROTEINS, HDL; PLACENTA; PREGNANCY;

EID: 81555210925     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00109.2011     Document Type: Article

References (46)

1. Argraves KM, Argraves WS. HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res 48: 2325-2333, 2007.
2. Asztalos BF, Tani M, Schaefer EJ. Metabolic and functional relevance of HDL subspecies. Curr Opin Lipidol 22: 176-185, 2011.
3. Averna MR, Barbagallo CM, Di Paola G, Labisi M, Pinna G, Marino G, Dimita U, Notarbartolo A. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns. Biol Neonate 60: 187-192, 1991.
4. Benjamini Y, Hochberg B. Controlling the false discovery rate: a powerful approach to multiple testing. J Roy Stat Soc B 57: 289-300, 1995.
5. Blum CB, Davis PA, Forte TM. Elevated levels of apolipoprotein E in the high density lipoproteins of human cord blood plasma. J Lipid Res 26: 755-760, 1985.
6. Cho KH. Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications. BMB Rep 42: 393-400, 2009.
7. Cooper MK, Wassif CA, Krakowiak PA, Taipale J, Gong R, Kelley RI, Porter FD, Beachy PA. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 33: 508-513, 2003.
8. Cress HR, Shaher RM, Laffin R, Karpowicz K. Cord blood hyperlipoproteinemia and perinatal stress. Pediatr Res 11: 19-23, 1977.
9. Davis PA, Forte TM, Nichols AV, Blum CB. Umbilical cord blood lipoproteins. Isolation and characterization of high density lipoproteins. Arteriosclerosis 3: 357-365, 1983.
10. Desoye G, Schweditsch MO, Pfeiffer KP, Zechner R, Kostner GM. Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab 64: 704-712, 1987.
11. Fielding CJ, Fielding PE. Membrane cholesterol and the regulation of signal transduction. Biochem Soc Trans 32: 65-69, 2004.
12. Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP. Multiple actions of high-density lipoprotein. Curr Opin Cardiol 23: 370-378, 2008.
13. Gauster M, Rechberger G, Sovic A, Horl G, Steyrer E, Sattler W, Frank S. Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. J Lipid Res 46: 1517-1525, 2005.
14. Gealekman O, Burkart A, Chouinard M, Nicoloro SM, Straubhaar J, Corvera S. Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Endocrinol Metab 295: E1056-E1064, 2008.
15. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 343: 425-430, 1990.
16. Goyer RA, Haust MD, Cherian MG. Cellular localization of metallothionein in human term placenta. Placenta 13: 349-355, 1992.
17. Guan G, Jiang G, Koch RL, Shechter I. Molecular cloning and functional analysis of the promoter of the human squalene synthase gene. J Biol Chem 270: 21958-21965, 1995.
18. Hagberg JM, Wilund KR, Ferrell RE. APO E gene and gene-environment effects on plasma lipoprotein-lipid levels. Physiol Genomics 4: 101-108, 2000.
19. Hassan HH, Denis M, Krimbou L, Marcil M, Genest J. Cellular cholesterol homeostasis in vascular endothelial cells. Can J Cardiol 22, Suppl B: 35B-40B, 2006.
20. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 7: 4119-4127, 1988.
21. Hovik R, Brodal B, Bartlett K, Osmundsen H. Metabolism of acetyl- CoA by isolated peroxisomal fractions: formation of acetate and acetoacetyl- CoA. J Lipid Res 32: 993-999, 1991.
22. Ito Y, Oike Y, Yasunaga K, Hamada K, Miyata K, Matsumoto S, Sugano S, Tanihara H, Masuho Y, Suda T. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res 63: 6651-6657, 2003.
23. Kumari MV, Hiramatsu M, Ebadi M. Free radical scavenging actions of metallothionein isoforms I and II. Free Radic Res 29: 93-101, 1998.
24. Lang I, Schweizer A, Hiden U, Ghaffari-Tabrizi N, Hagendorfer G, Bilban M, Pabst MA, Korgun ET, Dohr G, Desoye G. Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. Differentiation 76: 1031-1043, 2008.
25. Liadaki KN, Liu T, Xu S, Ishida BY, Duchateaux PN, Krieger JP, Kane J, Krieger M, Zannis VI. Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I. Effect of lipid association and APOA-I mutations on receptor binding. J Biol Chem 275: 21262-21271, 2000.
26. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630, 1988.
27. Marz W, Scharnagl H, Winkler K, Tiran A, Nauck M, Boehm BO, Winkelmann BR. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. Circulation 110: 3068-3074, 2004.
28. McGrath KC, Li XH, Puranik R, Liong EC, Tan JT, Dy VM, DiBartolo BA, Barter PJ, Rye KA, Heather AK. Role of 3betahydroxysteroid- delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 29: 877-882, 2009.
29. Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161: 1-16, 2002.
30. O'Connell BJ, Denis M, Genest J. Cellular physiology of cholesterol efflux in vascular endothelial cells. Circulation 110: 2881-2888, 2004.
31. Olivier LM, Krisans SK. Peroxisomal protein targeting and identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes. Biochim Biophys Acta 1529: 89-102, 2000.
32. Palinski W, Napoli C. Pathophysiological events during pregnancy influence the development of atherosclerosis in humans. Trends Cardiovasc Med 9: 205-214, 1999.
33. Parker CR Jr, Carr BR, Simpson ER, MacDonald PC. Decline in the concentration of low-density lipoprotein-cholesterol in human fetal plasma near term. Metabolism 32: 919-923, 1983.
34. Rindler MJ, Traber MG, Esterman AL, Bersinger NA, Dancis J. Synthesis and secretion of apolipoprotein E by human placenta and choriocarcinoma cell lines. Placenta 12: 615-624, 1991.
35. Sato M, Kondoh M. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J Exp Med 196: 9-22, 2002.
36. Sattler W, Mohr D, Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. Methods Enzymol 233: 469-489, 1994.
37. Sattler WB, Stocker R. Isolation of human VLDL, LDL, HDL and two subclasses in the TL-100 Tabletop centrifuge using the TLA-100.4 rotor. Technical Information, Ultracentrifugation. Beckman Instruments, Inc. 1992.
38. Schnablegger HG, O. Optical sizing of small colloidal particles: an optimized regularization technique. Appl Opt 30: 4889-4896, 1991.
39. Shimano H, Yamada N, Katsuki M, Shimada M, Gotoda T, Harada K, Murase T, Fukazawa C, Takaku F, Yazaki Y. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Proc Natl Acad Sci USA 89: 1750-1754, 1992.
40. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19: 7289-7304, 1999.
41. Steyrer E, Kostner GM. Activation of lecithin-cholesterol acyltransferase by apolipoprotein D: comparison of proteoliposomes containing apolipoprotein D, A-I or C-I. Biochim Biophys Acta 958: 484-491, 1988.
42. Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 18: 207-208, 2002.
43. Thompson SL, Krisans SK. Rat liver peroxisomes catalyze the initial step in cholesterol synthesis. The condensation of acetyl-CoA units into acetoacetyl-CoA. J Biol Chem 265: 5731-5735, 1990.
44. Vliagoftis H, Schwingshackl A, Milne CD, Duszyk M, Hollenberg MD, Wallace JL, Befus AD, Moqbel R. Proteinase-activated receptor-2- mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol 106: 537-545, 2000.
45. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77: 53-62, 1994.
46. Waterham HR, Koster J, Romeijn GJ, Hennekam RC, Vreken P, Andersson HC, FitzPatrick DR, Kelley RI, Wanders RJ. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 69: 685-694, 2001.